‘Remarkable’ drug reduces Alzheimer’s decline, study shows
Experts say trial provides more evidence that targeting plaque proteins in brain can slow the disease's progression.Experts say trial provides more evidence that targeting plaque proteins in brain can slow the disease's progression.